M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.82 EUR 2.09% Market Closed
Market Cap: 108.6m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

P/OCF
Price to OCF

-6
Current
-6.3
Median
21.6
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-6
=
Market Cap
108.8m EUR
/
Operating Cash Flow
-18.2m EUR
All Countries
Close
Market Cap P/OCF
FR
Maat Pharma SA
PAR:MAAT
108.8m EUR -6
FR
Pharnext SCA
OTC:PNEXF
6T USD -237 521.5
US
Abbvie Inc
NYSE:ABBV
320.1B USD 19.4
US
Amgen Inc
NASDAQ:AMGN
150.5B USD 20.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.4B USD -142.9
US
Gilead Sciences Inc
NASDAQ:GILD
113.8B USD 11.4
US
Epizyme Inc
F:EPE
94.1B EUR -473.6
AU
CSL Ltd
ASX:CSL
135.4B AUD 31.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.9B USD 19.5
US
Seagen Inc
F:SGT
39.3B EUR -76.5
NL
argenx SE
XBRU:ARGX
34.5B EUR -139.5
 
FR
M
Maat Pharma SA
PAR:MAAT
Average P/OCF: 20.5
Negative Multiple: -6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -237 521.5
US
Abbvie Inc
NYSE:ABBV
19.4
US
Amgen Inc
NASDAQ:AMGN
20.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -142.9
US
Gilead Sciences Inc
NASDAQ:GILD
11.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -473.6
AU
CSL Ltd
ASX:CSL
31.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -76.5
NL
argenx SE
XBRU:ARGX
Negative Multiple: -139.5

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More